SCHEMBL283516

SCHEMBL283516

CC1(C(=O)CC#N)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17351504 0.91 MCL1 (0.37)
SCHEMBL18692589 0.91 MCL1 (0.37)
SCHEMBL16541488 0.89 DPP4 (0.37)
SCHEMBL371371 0.89 DPP4 (0.37)
SCHEMBL12282538 0.86 RIPK1 (0.35)
SCHEMBL12614640 0.81 MEN1 (0.31)
SCHEMBL1255072 0.80 MCL1 (0.35)
SCHEMBL16866560 0.80 MCL1 (0.35)
SCHEMBL24410355 0.79 MCL1 (0.34)
Acetonitrile SCHEMBL25261563 0.77 MCL1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 100 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4728743-A Process for the production of 3-oxonitriles DEGUSSA AKTIENGESELLSCHAFT (DE) 1988-03-01 US claimed
US-4716237-A Process for the production of 3-oxonitriles DEGUSSA AKTIENGESELLSCHAFT (DE) 1987-12-29 US claimed
EP-0089011-A1 Process for the preparation of 5-oxonitriles Degussa Aktiengesellschaft (DE) 1983-09-21 EP claimed
CN-119060018-A N, N-diaryl urea derivative and application thereof 杭州百新生物医药科技有限公司 2024-12-03 CN disclosed
EP-2376478-B1 PYRIDYLOXYINDOLES INHIBITORS OF VEGF-R2 AND USE THEREOF FOR TREATMENT OF DISEASE NOVARTIS AG (CH) 2017-04-19 EP disclosed
EP-2376478-B1 PYRIDYLOXYINDOLES INHIBITORS OF VEGF-R2 AND USE THEREOF FOR TREATMENT OF DISEASE NOVARTIS AG (CH) 2017-04-19 EP disclosed
US-9193713-B2 Compounds as cannabinoid receptor ligands ABBVIE INC. (US) 2015-11-24 US disclosed
US-9169260-B2 Amidopyrazole inhibitors of interleukin receptor-associated kinases MERCK SHARP & DOHME CORP. (US) 2015-10-27 US disclosed
EP-2428507-B1 Cannabinoid receptor ligands ABBVIE BAHAMAS LTD (BS) 2015-10-21 EP disclosed
EP-2896615-A1 Cannabinoid receptor ligands AbbVie Bahamas Limited (BS) 2015-07-22 EP disclosed
EP-2851366-A1 Compounds as cannabinoid receptor ligands Abbvie Inc. (US) 2015-03-25 EP disclosed
US-4728743-A Process for the production of 3-oxonitriles DEGUSSA AKTIENGESELLSCHAFT (DE) 1988-03-01 US disclosed
US-4716237-A Process for the production of 3-oxonitriles DEGUSSA AKTIENGESELLSCHAFT (DE) 1987-12-29 US disclosed
EP-0129928-B1 OXAZOLYL-SUBSTITUTED DIAZAHETEROCYCLES SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1987-09-02 EP disclosed
EP-0089011-B1 PROCESS FOR THE PREPARATION OF 5-OXONITRILES Degussa Aktiengesellschaft (DE) 1985-07-10 EP disclosed
EP-0135252-A2 Process for preparing 3-substituted-3-aminonitrile ELI LILLY AND COMPANY (US) 1985-03-27 EP disclosed
US-4500345-A IOSTEMERGENCE AND PREEMERGENCE HERBICIDES SHELL OIL COMPANY (US) 1985-02-19 US disclosed
EP-0129928-A1 Oxazolyl-substituted diazaheterocycles SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1985-01-02 EP disclosed
EP-0129408-A2 (3-alkyl-5-isothiazolyl)ureas ELI LILLY AND COMPANY (US) 1984-12-27 EP disclosed
EP-0089011-A1 Process for the preparation of 5-oxonitriles Degussa Aktiengesellschaft (DE) 1983-09-21 EP disclosed